title: Positive results for drug combo in I-SPY 2 trial.
abstract: In results from one part of the I-SPY 2 trial announced at the 2013 San Antonio Breast Cancer Symposium, neoadjuvant veliparib plus carboplatin improved outcomes for women with triple-negative breast cancer.
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy; D064726:Triple Negative Breast Neoplasms / Q000188:drug therapy*